BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace- Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future” ... Читать дальше...